2nd of November 2026

GLP-1 companions: Decoding the category

PharmaLinea brings together insights to help brands understand what’s shaping the emerging GLP-1 companions supplement category.

Most people recognize the opportunity GLP-1 medications are creating in supplements. Few understand the ecosystem forming around them.

As GLP-1 use grows, a new category of companion products is emerging around the patient journey. Yet many questions remain unanswered. Who are these consumers? Do they all experience the same challenges? What support are they looking for beyond the medication itself? How are their behaviors, purchasing habits, and expectations changing? And what role can supplement brands credibly play?

To answer these questions, PharmaLinea is bringing together different perspectives on the patient journey, consumer behavior, and market developments to help brands better understand the forces shaping the GLP-1 companions category. The full speaker lineup will be announced soon.

2

content
tracks

12

expert
speakers

3

content
types

Join us live on November 26th to discover:

  • What is the GLP-1 companions category?
  • What do patients experience and need throughout their GLP-1 journey?
  • How are patients adapting their nutrition, routines, and purchasing behavior?
  • How are consumers discovering, evaluating, and purchasing companion products?
  • Where are the most credible opportunities for supplement brands?
  • What could effective GLP-1 companion solutions look like in practice?

Why register?

The opportunity is clear. The category is not. If you’re looking to better understand GLP-1 consumers, the needs emerging throughout their journey, and how your brand can respond with meaningful companion solutions, this event is for you.

Can’t join live? Register anyway, and we’ll share the recording and presentation materials after the event.

timeline.

keynote

10:00

NUTRACEUTICAL TRENDS FOR 2026 & BEYOND

Presentation (30 min)

Matevž Ambrožič,

Marketing Director

What kind of nutraceuticals to launch in 2026 and beyond? What can we make of the recent data, and which white spaces should we look out for in the coming years? This keynote will focus on the current trends, affecting the nutraceutical industry, key up and coming ingredients, and new marketing strategies with surprising results. We will support this with solid market data, recent product and ingredient launch examples, and quotes from experts.

marketing track

scientific track

10:30

CONSUMER HEALTH MARKET OVERVIEW – PERFORMANCE, TRENDS & FORECAST

Presentation (30 min)

Amit Shukla,

VP & GM, Consumer Health & MedTech Consulting Services

The presentation will focus on the OTC market performance over the last MAT, specifically looking at various regions and OTC categories. From there, the topic will cover key market trends in digital, e-commerce, retail, and so forth. The session will conclude with a forecast for the global OTC market, the European OTC market, and key future drivers.

11:00

PERSPECTIVES FROM THE MOROCCAN MARKET: FEW KEY DRIVERS

Presentation (20 min)

Sophia Babi Berrada,

Nutri’5 Business Unit Manager

Taking care of one’s health and well-being is increasingly at the heart of patients’ expectations. To better meet these growing needs, Pharma 5 Group chose to innovate and further diversify its portfolio by creating the Group’s Nutrition Business Unit Nutri5. The case study will focus on the business unit’s success and present the four key drivers of its strategic journey.

11:20

CASE STUDY: STRATEGIC PORTFOLIO MANAGEMENT FOR SUSTAINABLE GROWTH

Presentation (20 min)

Maud Belicchi,

Head of Product Design & Portfolio Management

Determining market success in the highly competitive healthcare industry requires balancing rapid innovation with long-term brand strategy. This case study offers practical guidance for brand owners and portfolio managers in the healthcare and nutraceutical sectors to move beyond short-term product sprints towards sustainable, consistent growth.

Participants will learn how to assess and implement high-value innovation by integrating it with 360° Portfolio Management strategies, including the use of specific lifecycle management tools, key mindset shifts, and dedicated processes. Concrete examples and results will illustrate how these principles can be applied in practice to maximize brand equity, ensure portfolio consistency, and drive enduring market leadership.

11:45

SCALING A NUTRACEUTICAL BUSINESS

Roundtable panel (30 min)

Lorna Vanderhaeghe,

President

Blaž Gorjup,

Founder

Miquel Àngel Bonachera,

Executive Director & Co-Founder

This roundtable with founders from AB-Biotics, Headlines Promotions Inc, and PharmaLinea, will focus on the tools and strategies that can help build and scale a successful nutraceutical business.

12:15

DESIGNING THE FUTURE OF NUTRACEUTICAL BRANDS

Workshop (1 h)

Lindsey Figarol,

Account Director

Matt Taylor,

Design Director

In an increasingly competitive nutraceutical market, the difference between a product and a brand lies in the power of design. In this live, interactive workshop led by brand elevation agency and specialists in health, wellness and pharmaceutical design – Free The Birds – participants will step into the shoes of a creative team responding to a real-world brief.

Attendees will explore how strategic storytelling, distinctive visual identity, and design thinking can transform science-led healthcare products into emotionally engaging brands which are built for longevity.

Working in small groups, participants will develop quick concepts based on a brief provided, before sharing their ideas with the hosts for discussion and feedback. Together, we’ll uncover what makes a nutraceutical brand not only credible and compliant, but also truly compelling.

Expect practical insights, creative inspiration, and a behind-the-scenes look at how the world’s leading health and wellness brands turn functional benefits into meaningful connections.

10:30

BOTANICALS AND NOVEL FOOD STATUS: PRACTICAL GUIDANCE AND CASE STUDIES

Presentation (30 min)

Jérôme Le Bloch,

Head of Scientific Affairs

Determining whether a botanical ingredient is considered a novel food under EU regulation can be challenging. This session offers practical guidance for professionals in the nutraceutical and food supplement industry to navigate this process effectively. Participants will learn how to assess the novel food status of ingredients using key regulatory tools such as the EU Novel Food Catalogue, the Union List of Novel Foods (Regulation (EU) 2017/2470), and insights from consultation processes under Article 4 of Regulation (EU) 2015/2283. Concrete case studies on botanical extracts will illustrate how these principles can be applied in practice.

11:00

UNLOCKING HOLISTIC HEALTH: HOW EMERGING BOTANICALS SUPPORT 5 KEY AREAS OF HEALTH

Presentation (30 min)

David Foreman,

RPh/President

Discover how innovative botanicals are transforming the landscape of holistic health. This presentation explores the science and potential of emerging “plant-based” ingredients to support five key pillars of well-being: metabolic health, women’s health, beauty from within, mental wellness, and active aging. Learn how these botanicals can address modern health challenges, promote vitality, and empower individuals to thrive at every stage of life.

11:30

THE NEW ERA OF CLINICAL TRIALS: HOW AI, DIGITAL TECH & REAL-WORLD EVIDENCE ARE FUELING FASTER INNOVATION

Presentation (30 min)

Pelin Thorogood,

Co-Founder & Executive Chairwoman

AI, citizen science, and rich streams of digital data are transforming how rigorous clinical evidence is generated—shifting trials from slow, site-based studies to agile, decentralized, real-world evidence generation. In this trends-focused session, we’ll explore how this shift is rewriting the playbook for R&D, innovation, and business teams in supplements, functional foods, and beyond.

You’ll discover how validated digital endpoints, integrated wearable and sensor data, and AI-derived signals are augmenting traditional biomarkers to deliver faster, more inclusive, and more decision-ready clinical findings. We’ll walk through real examples—from Bluetooth-connected scales and smartphone-based cognition tests to AI-analyzed facial scans and multi-sensor wearables—showing how continuous, multimodal data can be translated into clinically meaningful, regulator-ready insights.

We’ll also zoom out to connect the dots on where AI, big data, and modern trial design are heading next—and what that means for the innovation roadmap for precision wellness.

If you’re responsible for driving innovation, turning wellness ideas into proven precision products, this session is your cheat sheet to the future of evidence.

12:00

ACTIVE AGEING: A LIVE EXERCISE AT THE NEXUS OF ACTIVE NUTRITION & HEALTHY AGEING

Workshop (1 h)

Kenn Israel,

Founder

We will collectively take on a “Right-to-Own” category that will dominate thinking in the nutraceuticals industry for years to come. We will formulate products for a population that wants to show up as the best version of themselves every day, regardless of their starting point. Maximizing HealthSpan and performance in our everyday life goes to the core of everyone’s health journey and we will create new formulations to address these essential needs.

Our event organizers will divide participants into groups. The groups will draw a Healthspan Attribute, Delivery System, Market Channel, and the Hero of their Products Story (Every product has a story) and each group will create a formulation. We will then present our work to the entire group.

scientific track

10:30

BOTANICALS AND NOVEL FOOD STATUS: PRACTICAL GUIDANCE AND CASE STUDIES

Presentation (30 min)

Jérôme Le Bloch,

Head of Scientific Affairs

Determining whether a botanical ingredient is considered a novel food under EU regulation can be challenging. This session offers practical guidance for professionals in the nutraceutical and food supplement industry to navigate this process effectively. Participants will learn how to assess the novel food status of ingredients using key regulatory tools such as the EU Novel Food Catalogue, the Union List of Novel Foods (Regulation (EU) 2017/2470), and insights from consultation processes under Article 4 of Regulation (EU) 2015/2283. Concrete case studies on botanical extracts will illustrate how these principles can be applied in practice.

11:00

UNLOCKING HOLISTIC HEALTH: HOW EMERGING BOTANICALS SUPPORT 5 KEY AREAS OF HEALTH

Presentation (30 min)

David Foreman,

RPh/President

Discover how innovative botanicals are transforming the landscape of holistic health. This presentation explores the science and potential of emerging “plant-based” ingredients to support five key pillars of well-being: metabolic health, women’s health, beauty from within, mental wellness, and active aging. Learn how these botanicals can address modern health challenges, promote vitality, and empower individuals to thrive at every stage of life.

11:30

THE NEW ERA OF CLINICAL TRIALS: HOW AI, DIGITAL TECH & REAL-WORLD EVIDENCE ARE FUELING FASTER INNOVATION

Presentation (30 min)

Pelin Thorogood,

Co-Founder & Executive Chairwoman

AI, citizen science, and rich streams of digital data are transforming how rigorous clinical evidence is generated—shifting trials from slow, site-based studies to agile, decentralized, real-world evidence generation. In this trends-focused session, we’ll explore how this shift is rewriting the playbook for R&D, innovation, and business teams in supplements, functional foods, and beyond.

You’ll discover how validated digital endpoints, integrated wearable and sensor data, and AI-derived signals are augmenting traditional biomarkers to deliver faster, more inclusive, and more decision-ready clinical findings. We’ll walk through real examples—from Bluetooth-connected scales and smartphone-based cognition tests to AI-analyzed facial scans and multi-sensor wearables—showing how continuous, multimodal data can be translated into clinically meaningful, regulator-ready insights.

We’ll also zoom out to connect the dots on where AI, big data, and modern trial design are heading next—and what that means for the innovation roadmap for precision wellness.

If you’re responsible for driving innovation, turning wellness ideas into proven precision products, this session is your cheat sheet to the future of evidence.

12:00

ACTIVE AGEING: A LIVE EXERCISE AT THE NEXUS OF ACTIVE NUTRITION & HEALTHY AGEING

Workshop (1 h) – WORKSHOP FULL

Kenn Israel,

Founder

We will collectively take on a “Right-to-Own” category that will dominate thinking in the nutraceuticals industry for years to come. We will formulate products for a population that wants to show up as the best version of themselves every day, regardless of their starting point. Maximizing HealthSpan and performance in our everyday life goes to the core of everyone’s health journey and we will create new formulations to address these essential needs.

Our event organizers will divide participants into groups. The groups will draw a Healthspan Attribute, Delivery System, Market Channel, and the Hero of their Products Story (Every product has a story) and each group will create a formulation. We will then present our work to the entire group.

speakers.

Chloé Arjona has over 10 years of experience in the beauty industry, within leading groups such as Puig, Coty and Shiseido. Since 2022, she has been leading NellyRodi’s Beauty & Wellbeing Division, addressing industry players' challenges around brand desirability, relevance, and performance.

Beauty & Wellbeing Director at NellyRodi

Chloé Arjona

Matevž Ambrožič has an academic background in biochemistry, with a specialty in protein biochemistry. He decided to apply his knowledge to nutraceuticals and took on the position he currently holds at PharmaLinea.

Strategy Director at PharmaLinea

Matevž Ambrožič

awards.

"*" indicates required fields

PharmaLinea © 2026